An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates
An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates Pediatric Pharmacology Research Unit, Children's Hospital of Michigan
Sponsor: Children's Hospital of Michigan
A PHASE1 clinical study on Bacterial Infection and Ureaplasma, this trial is completed. The trial is conducted by Children's Hospital of Michigan and has accumulated 4 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE1
First recorded
Sep 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital of Michigan
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Pediatric Pharmacology Research Units Network
For direct contact, visit the study record on ClinicalTrials.gov .